Transamerica Financial Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604 | Sell |
17
-1,419
| -99% | -$50.4K | ﹤0.01% | 427 |
|
|
2025
Q1 | $45K | Sell |
1,436
-496
| -26% | -$15.5K | ﹤0.01% | 312 |
|
|
2024
Q4 | $50K | Sell |
1,932
-1,527
| -44% | -$39.5K | ﹤0.01% | 314 |
|
|
2024
Q3 | $98K | Buy |
3,459
+1,729
| +100% | +$49K | 0.01% | 274 |
|
|
2024
Q2 | $46K | Hold |
1,730
| – | – | ﹤0.01% | 278 |
|
|
2024
Q1 | $53K | Sell |
1,730
-6,633
| -79% | -$203K | 0.01% | 300 |
|
|
2023
Q4 | $235K | Sell |
8,363
-2,234
| -21% | -$62.8K | 0.03% | 233 |
|
|
2023
Q3 | $288K | Sell |
10,597
-1,430
| -12% | -$38.9K | 0.04% | 197 |
|
|
2023
Q2 | $370K | Sell |
12,027
-2,990
| -20% | -$92K | 0.05% | 194 |
|
|
2023
Q1 | $542K | Buy |
15,017
+3,147
| +27% | +$114K | 0.07% | 170 |
|
|
2022
Q4 | $470K | Buy |
11,870
+203
| +2% | +$8.04K | 0.07% | 171 |
|
|
2022
Q3 | $469K | Sell |
11,667
-1,247
| -10% | -$50.1K | 0.07% | 166 |
|
|
2022
Q2 | $543K | Buy |
+12,914
| New | +$543K | 0.08% | 161 |
|